FDA Adverse Event Death Summary report: N

GORE TAG THORACIC ENDOPROSTHESIS

MDR report key: 1904043 · Received November 15, 2010

Report

Report Number
2017233-2010-00506
Event Type
Death
Date Received
November 15, 2010
Date of Event
October 25, 2010
Report Date
November 15, 2010
Manufacturer
W.L. GORE & ASSOCIATES
Product Code
MIH
PMA / PMN Number
P040043
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IL, US
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

A REVIEW OF THE MFG PAPERWORK WAS CONDUCTED. THE REVIEW OF THE MFG PAPERWORK VERIFIED THAT THIS LOT MET ALL PRE-RELEASE SPECIFICATIONS. AS STATED IN THE GORE TAG THORACIC ENDOPROSTHESIS INSTRUCTIONS FOR USE, THE GORE TAG DEVICE PROVIDES ENDOVASCULAR REPAIR OF ANEURYSMS OF THE DESCENDING THORACIC AORTA. COMPLICATIONS ASSOCIATED WITH THE USE OF THE GORE TAG DEVICE MAY INCLUDE, BUT ARE NOT LIMITED TO, ENDOLEAK, REOPERATION, CARDIAC (E.G. ARRHYTHMIA, MYOCARDIAL INFARCTION, CONGESTIVE HEART FAILURE, HYPOTENSION OR HYPERTENSION), VASCULAR SPASM OR VASCULAR TRAUMA (E.G. ILIO-FEMORAL VESSEL DISSECTION, BLEEDING, RUPTURE), AND DEATH.

Description of Event or Problem · 1

ON (B)(6) 2007, THE PT WAS IMPLANTED WITH FOUR GORE TAG THORACIC ENDOPROSTHESES TO TREAT AN AORTIC ARCH ANEURYSM. THE PROCEDURE INCLUDED DE-BRANCHING OF VESSELS IN THE TRANSVERSE ARCH. ON (B)(6) 2010, A REINTERVENTION OCCURRED TO TREAT A DISTAL TYPE-1 ENDOLEAK AND A SUSPECTED TYPE-3 ENDOLEAK. A CONDUIT WAS BEING USED TO INTRODUCE A GORE TAG THORACIC ENDOPROSTHESIS; HOWEVER, THE RIGHT COMMON ILIAC ARTERY RUPTURED (BEFORE THE DEVICE ENTERED THE PT) AND BLOOD PRESSURE DROPPED. THE RUPTURE WAS REPAIRED, BUT TOTAL BLOOD LOSS EXCEEDED 1 LITER. THE GORE TAG DEVICE WAS IMPLANTED DURING ONGOING ATTEMPTS TO STABILIZE THE PT; HOWEVER, THE PT DIED INTRA-OPERATIVELY.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 GORE TAG THORACIC ENDOPROSTHESIS MIH/ SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT MIH W.L. GORE & ASSOCIATES WLG426 03879190

Patients

Seq Age Sex Outcome Treatment
1 81 YR Death| H| L| R TG4020/(B)(4)| TG4020/(B)(4)| TGT4520/(B)(4)| TG4020/(B)(4)